intercure.co - התחייבויות לטווח ארוך של החברה INCR

This price chart for InterCure Ltd. (INCR), which specializes in psychotropic drugs, captures the 0.02 metric. Current quotes are pressured by Middle Eastern logistics issues and slow progress in European legislation. Stable demand for treatment offsets moderate cyclicality, although inflation impacts revenue. Meanwhile, military conflicts in the region of operation pose real threats to infrastructure and block product exports.

Long-term debt measures the total liabilities with a maturity of more than one year, where an increase in this indicator signals rising credit risk and potential pressure from interest expenses on net income. By analyzing the level of the business's long-term borrowed capital, an investor can assess the financial stability of InterCure Ltd. (INCR) during the scaling of its pharmacy network and the expansion of medical cannabis across European markets.